15.09.2020 | Original Article Open Access
Patient reported outcome measures concerning urinary incontinence after robot assisted radical prostatectomy: development and validation of an online prediction model using clinical parameters, lower urinary tract symptoms and surgical experience
- Zeitschrift:
- Journal of Robotic Surgery
Electronic supplementary material
Publisher's Note
Introduction
Patients and methods
Patients
Defining urinary (in)continence
Pre-operative parameters
Per-operative parameters
Outcome measures
Statistical analyses
Results
Variable
|
Frequency
|
---|---|
Age (years)
|
Median 66 years (range 40–79)
|
≤ 60
|
21.6% (392/1814)
|
61–64
|
19.9% (361/1814)
|
65–67
|
20.1% (364/1814)
|
68–70
|
19.1% (347/1814)
|
≥ 71
|
19.3% (350/1814)
|
ASA (score)
|
|
1
|
32% (573/1814)
|
2
|
64% (1170/1814)
|
3
|
4% (71/1814)
|
BMI (index)
|
Median 26 (range 16–54)
|
Normal (< 25)
|
30.3% (550/1814)
|
Overweight (25–30)
|
56.3% (1021/1814)
|
Obese (> 30)
|
13.4% (243/1814)
|
Prostate volume (mL)
|
Median 54 mL (range 17–260)
|
≤ 50
|
43.0% (780/1814)
|
51–65
|
27.4% (497/1814)
|
> 65
|
29.6% (537 / 1,814)
|
Initial PSA (ug/l)
|
median 9.0 ng/mL (range 0.6–172.0)
|
Pre-operative LUTS (IPSS score)
|
Median 9 (range 0–35)
|
No or mild (0–7)
|
43.2% (784/1814)
|
Moderate (8–19)
|
43.2% (785/1814)
|
Severe (20–35)
|
13.5% (245/1814)
|
Case numbers per surgeon
|
|
Surgeon 1 “senior”
|
81.0% (1469/1814)
|
Surgeon 2 “novice”
|
8.0% (146/1814)
|
Surgeon 3 “novice”
|
8.4% (153/1814)
|
Surgeon 4 “novice”
|
2.5% (46/1814)
|
Surgical caseload
|
|
Cases by “novice” surgeon (1–100 cases)
|
11.0% (200/1814)
|
Cases by “senior” surgeon (> 100 cases)
|
89.0% (1614/1814)
|
Nerve sparing prostatectomy groups
|
|
Group 1—Bilateral nerve sparing
|
54.6% (990/1814)
|
Group 2—Left or Right or Partial (one sided)
|
25.7% (466/1814)
|
Group 3—No nerve sparing
|
19.7% (358/1814)
|
Primary outcome of PPI
Univariate and multivariate analysis of PPI
Pre- and per-operative variables
|
Continence (0 or 1 safety pad)
|
p value*
|
---|---|---|
ASA—status 1
|
83.2% (477/573)
|
0.010
|
ASA—status 2
|
79.2% (927/1170)
|
|
ASA—status 3
|
69.4% (49/71)
|
|
BMI—normal < 25
|
80.6% (443/550)
|
0.039
|
BMI—overweight 25–30
|
81.3% (830/1021)
|
|
BMI—obese > 30
|
74.1% (180/243)
|
|
Prostate volume—≤ 50 mL
|
83.6% (652/780)
|
0.001
|
Prostate volume—51–65 mL
|
79.8% (397/497)
|
|
Prostate volume—> 65 mL
|
75.0% (403/537)
|
|
Age ≤ 60 years
|
84.1% (333/396)
|
0.001
|
Age 61–64 years
|
82.9% (300/263)
|
|
Age 65–67 years
|
83.1% (304/366)
|
|
Age 68–70 years
|
75.0% (261/348)
|
|
Age ≥ 71 years
|
74.6% (262/351)
|
|
LUTS—no or mild
|
83.5% (638/764)
|
0.002
|
LUTS—moderate
|
79.2% (609/769)
|
|
LUTS—severe
|
73.6% (178/242)
|
|
Nerve sparing group 1—bilateral NS
|
84.9% (841/990)
|
0.001
|
Nerve sparing group 2—left or right or partial (one sided)
|
74.4% (332/466)
|
|
Nerve sparing group 3—non NS
|
74.3% (266/358)
|
|
Novice surgeon 1–100 RARPs
|
72.5% (145/200)
|
0.004
|
Senior surgeon > 100 RARPs
|
81.0% (1307/1614)
|
Pre- and per-operative variables
|
Large model*
|
Small model*
|
|||
---|---|---|---|---|---|
OR (odds ratio)
|
p value
|
OR (odds ratio)
|
p value
|
95% CI
|
|
Nerve sparing group 1—bilateral NS
|
1
|
0.001
|
1
|
< 0.001
|
|
Nerve sparing group 2—left or right or partial (one sided)
|
0.60
|
0.58
|
0.44–0.77
|
||
Nerve sparing group 3—non NS
|
0.62
|
0.58
|
0.43–0.80
|
||
LUTS—no or mild
|
1
|
0.010
|
1
|
0.004
|
|
LUTS—moderate
|
0.75
|
0.75
|
0.58–0.97
|
||
LUTS—severe
|
0.59
|
0.56
|
0.40–0.80
|
||
Novice surgeon 1–100 RARPs
|
1
|
0.012
|
1
|
0.025
|
|
Senior surgeon > 100 RARPs
|
1.6
|
1.5
|
1.05–2.1
|
||
Age ≤ 60 years
|
1
|
0.11
|
1
|
0.049
|
|
Age 61–64 years
|
1.05
|
1.01
|
0.68–1.5
|
||
Age 65–67 years
|
1.1
|
1.04
|
0.70–1.5
|
||
Age 68–70 years
|
0.70
|
0.67
|
0.46–0.97
|
||
Age ≥ 71 years
|
0.79
|
0.73
|
0.50–1.1
|
||
ASA—status 1
|
1
|
0.22
|
n.s
|
||
ASA—status 2
|
0.88
|
||||
ASA—status 3
|
0.60
|
||||
Prostate volume—≤ 50 mL
|
1
|
0.13
|
n.s
|
||
Prostate volume—51–65 mL
|
0.91
|
||||
Prostate volume—> 65 mL
|
0.74
|
||||
BMI—normal < 25
|
1
|
0.11
|
n.s
|
||
BMI—overweight 25–30
|
1.1
|
||||
BMI—obese > 30
|
0.77
|